Related references
Note: Only part of the references are listed.ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer
Kai Li et al.
CELL RESEARCH (2020)
Metabolic regulation of cell growth and proliferation
Jiajun Zhu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2
Laurel M. Pegram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Mathematical Model for Enzyme Clustering in Glucose Metabolism
Miji Jeon et al.
SCIENTIFIC REPORTS (2018)
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors
Stergios J. Moschos et al.
JCI INSIGHT (2018)
Identification of a multienzyme complex for glucose metabolism in living cells
Casey L. Kohnhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis
Jia Zhang et al.
NATURE COMMUNICATIONS (2017)
Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
Jong-Ho Lee et al.
NATURE COMMUNICATIONS (2017)
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Ping Wee et al.
CANCERS (2017)
EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
Seung-Oe Lim et al.
CANCER RESEARCH (2016)
Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis
Xinjian Li et al.
MOLECULAR CELL (2016)
A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
Michael E. Pacold et al.
NATURE CHEMICAL BIOLOGY (2016)
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
Apirat Chaikuad et al.
NATURE CHEMICAL BIOLOGY (2014)
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Xavier Deschenes-Simard et al.
GENES & DEVELOPMENT (2013)
Akt Phosphorylates HK-II at Thr-473 and Increases Mitochondrial HK-II Association to Protect Cardiomyocytes
David J. Roberts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Akt-dependent Activation of the Heart 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase (PFKFB2) Isoenzyme by Amino Acids
Laura Novellasdemunt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Frequency-Modulated Pulses of ERK Activity Transmit Quantitative Proliferation Signals
John G. Albeck et al.
MOLECULAR CELL (2013)
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
Erick J. Morris et al.
CANCER DISCOVERY (2013)
Network Analysis of Epidermal Growth Factor Signaling Using Integrated Genomic, Proteomic and Phosphorylation Data
Katrina M. Waters et al.
PLOS ONE (2012)
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato et al.
NATURE (2011)
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Jason W. Locasale et al.
NATURE GENETICS (2011)
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Heather R. Christofk et al.
NATURE (2008)
A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen
John M. Asara et al.
PROTEOMICS (2008)
Reversible compartmentalization of de novo purine biosynthetic complexes in living cells
Songon An et al.
SCIENCE (2008)
The epidermal growth factor receptor pathway: A model for targeted therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2006)
Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling
KN Thimmaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
